We, thus, examined whether the occupancy of SHP and DNMT3A and DNA methylation at lipogenic genes are altered in NAFLD patients with steatosis or NASH-fibrosis. The gene discussed is NR0B2; the disease is metabolic dysfunction-associated steatotic liver disease.